Vaxia Pharma Tesamorelin 40mg Pen

Vaxia Pharma Tesamorelin 40mg Pen

Vaxia Pharma Tesamorelin 40mg Pen is a prefilled pen formulation containing tesamorelin, a synthetic peptide that acts on growth hormone-releasing hormone (GHRH) receptors. The product is labelled with a total content of 40mg, presented in a pen format containing four labelled 10mg doses.

The packaging includes six disposable needles and specifies refrigerated storage. Product handling and storage should follow the manufacturer’s documentation and applicable requirements.

Research Areas

Tesamorelin is studied in scientific research relating to:

• Growth hormone-releasing hormone signalling
• Pituitary hormone regulation
• Peptide structure and biochemical activity
• Endocrine signalling pathways
• Growth hormone-related biological processes

Key Features

• Brand: Vaxia Pharma
• Product: Tesamorelin Pen
• Total labelled content: 40mg
• Labelled format: Four doses of 10mg
• Delivery format: Prefilled pen
• Packaging: Six disposable needles
• Storage: Keep refrigerated and do not freeze, as indicated on the packaging

Research Reference

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It is investigated in scientific studies examining interactions with GHRH receptors and related endocrine signalling pathways.

This product should only be handled by qualified professionals in accordance with applicable regulations and appropriate documentation.

Not intended for human consumption or self-administration.

What Is Tesamorelin?

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone. It is designed to interact with GHRH receptors and is studied in relation to the regulation of growth hormone secretion and associated biological pathways.

Research Disclaimer : Vaxia Pharma Tesamorelin 40mg Pen

For laboratory and scientific research use only, where legally permitted. Not intended for human consumption, self-administration, diagnosis, treatment, or prevention of disease.